NSAIDs do carry ototoxic potential, though the risk varies widely depending on the specific drug, the dose, and how long you take it. The most well-documented culprit is aspirin (a salicylate), which can cause reversible hearing loss and tinnitus at moderate to high doses, but ibuprofen, naproxen, and other non-aspirin NSAIDs have also been linked to hearing changes in both clinical reports and large population studies. The picture is more nuanced than a simple yes-or-no, because NSAIDs sit in an unusual category: they are among the most commonly used medications on the planet, yet their hearing effects tend to be subtle enough that most people never notice them.
How NSAIDs Affect the Inner Ear
The inner ear depends on a delicate electrochemical environment to convert sound vibrations into nerve signals. Outer hair cells, the tiny structures responsible for amplifying sound inside the cochlea, are particularly sensitive to chemical disruption. Aspirin and related salicylates can reversibly shut down the motor protein in those cells, called prestin, which is what gives them their ability to move and amplify incoming sound.1PubMed Central. Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression When prestin stops working properly, the cochlea loses amplification, and you perceive that as a drop in hearing sensitivity.
Beyond direct interference with hair cell function, NSAIDs also reduce blood flow to the cochlea. The inner ear’s blood supply is already minimal compared with most organs, so even small reductions matter. Research suggests the mechanism involves prostaglandins and leukotrienes, the same inflammatory signaling molecules that NSAIDs are designed to suppress elsewhere in the body. Blocking prostaglandin production in the cochlea constricts local blood vessels, reducing the oxygen and nutrient delivery that hair cells need to function.2Otolaryngologic Clinics of North America. Ototoxicity of Salicylate, Nonsteroidal Antiinflammatory Drugs, and Quinine This dual hit, direct cellular disruption plus reduced blood flow, explains why NSAIDs can affect hearing even at doses that seem reasonable for pain relief.
What the Large Population Studies Show
Two major studies have tracked analgesic use and hearing loss across tens of thousands of people, and both found a modest but real increase in risk with regular NSAID use. In a study following roughly 27,000 men for up to 18 years, regular users of non-aspirin NSAIDs had about a 21% higher risk of hearing loss compared with men who used them less than twice a week. Aspirin users had a 12% higher risk, and acetaminophen users about a 22% higher risk. For NSAIDs and acetaminophen, the risk climbed with longer duration of regular use.3PubMed Central. Analgesic Use and the Risk of Hearing Loss in Men
A parallel study in nearly 56,000 women from the Nurses’ Health Study found a similar pattern. Women who used NSAIDs for more than six years had about a 10% higher risk of self-reported hearing loss compared with those who used them for less than a year. Acetaminophen showed a comparable increase. Aspirin, interestingly, did not show a significant duration-dependent risk in this cohort.4PubMed Central. Duration of Analgesic Use and Risk of Hearing Loss in Women The differences between the men’s and women’s results are worth noting: the relative risks are in the same general range (roughly 10% to 22% higher), but the specific patterns by drug type and duration don’t line up perfectly. Both studies relied on self-reported hearing difficulty, which introduces its own limitations, but the consistency in direction across two large, well-controlled cohorts is hard to dismiss.
A separate analysis looking at longer-term exposure found that people taking NSAIDs had about a 45% greater risk of progressive hearing loss over a 40-year period compared with non-users, a substantially larger effect estimate that likely reflects the cumulative nature of very long-term exposure.5Frontiers in Neuroscience. Age-related hearing loss in older adults: etiology and rehabilitation strategies – Section: 3.2.5 Ototoxic drugs These numbers don’t mean that nearly half of NSAID users will go deaf; they mean that, all else being equal, regular long-term use nudges the probability of measurable hearing decline upward by a meaningful amount.
Aspirin’s Unusual Double Role
Aspirin occupies a strange position in the ototoxicity conversation. At high doses, such as those once commonly used for rheumatic conditions, it reliably causes tinnitus and measurable hearing loss. The mechanism is well understood: salicylate molecules interfere with prestin in outer hair cells, reducing the cochlea’s amplification capacity. The good news is that this effect is almost always reversible. Stop taking the aspirin, and hearing returns to baseline within a day or two in most cases.
At low doses, however, aspirin may actually protect the ear. Research suggests that low-dose aspirin can reduce hearing damage from noise exposure or from other ototoxic drugs, because its anti-inflammatory and antioxidant properties help limit the oxidative stress and inflammation that noise and certain chemicals trigger in the cochlea.6PubMed Central. Aspirin in Audiology: A Dual-Edged Sword in Hearing Loss and Its Nanotechnology-Driven Future So the same drug that causes hearing loss at high doses may prevent it at low doses, depending on the context. This is one of the more fascinating wrinkles in ototoxicity research, and it underscores why blanket statements about NSAIDs and hearing don’t hold up well.
Non-Aspirin NSAIDs and Sudden Hearing Loss
While the gradual hearing decline from long-term use gets the most attention in population studies, NSAIDs have also been linked to rare cases of sudden sensorineural hearing loss, which is a more dramatic and alarming event. Naproxen, one of the most commonly used over-the-counter NSAIDs, has tinnitus and transient hearing loss listed among its known side effects. Sudden sensorineural hearing loss from NSAID use is rare, but it has been documented in case reports.7Military Medicine. Naproxen-Associated Sudden Sensorineural Hearing Loss
The distinction matters practically. Gradual hearing loss from chronic use may creep up on you over years, and you might never connect it to your ibuprofen habit. Sudden hearing loss, by contrast, is impossible to miss and should prompt immediate medical attention regardless of what you think caused it. If you experience a noticeable drop in hearing shortly after starting an NSAID or increasing your dose, it’s worth mentioning the timing to your doctor rather than assuming the two are unrelated.
Topical NSAIDs Applied Directly to the Ear
Most people encounter NSAIDs as pills, but some formulations are designed for direct application to the ear, particularly in the treatment of ear infections and inflammation. This route of delivery raises different ototoxicity concerns because the drug reaches the inner ear in much higher local concentrations than it would through the bloodstream. An animal study testing diclofenac sodium as ear drops found that chronic topical use was as ototoxic as gentamicin, an antibiotic well known for causing permanent hearing damage. The risk was highest when the eardrum was perforated, which is exactly the scenario common in chronic ear infections where these drops might be prescribed.8International Journal of Pediatric Otorhinolaryngology. Ototoxicity associated with topical administration of diclofenac sodium as an otic drop: An experimental animal study
This finding is worth flagging because people tend to think of ear drops as mild, localized treatments. The idea that an anti-inflammatory ear drop could damage hearing as effectively as a notoriously ototoxic antibiotic is genuinely surprising, and it’s the kind of risk that doesn’t get much airtime outside specialist literature. If you have a perforated eardrum and are prescribed NSAID-containing ear drops, the potential for inner ear exposure is real.
NSAIDs and Noise Exposure Together
A common practical question is whether taking an NSAID before or during noise exposure, such as a concert, a shooting range, or a loud workday, makes hearing damage worse. The answer is not straightforward. One animal study tested celecoxib, a COX-2 selective NSAID, and found that pretreating with it before noise exposure led to slightly higher hearing threshold shifts than noise alone. The difference wasn’t statistically significant, but the trend was in the wrong direction; the drug didn’t protect against noise damage and may have worsened it slightly.9PubMed Central. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
This contrasts with the evidence that low-dose aspirin may be protective against noise damage, as described earlier. The discrepancy probably reflects the different pharmacological profiles of different NSAIDs: aspirin has antioxidant properties that other NSAIDs don’t share to the same degree, and COX-2 inhibitors like celecoxib work through a narrower pathway. The practical takeaway is that you shouldn’t assume taking ibuprofen before a loud event will protect your hearing, and there’s at least suggestive evidence that it could make things marginally worse.
Children with Chronic Inflammatory Conditions
Children with juvenile idiopathic arthritis often take NSAIDs for extended periods, sometimes years, making them a population of particular interest for ototoxicity monitoring. Two studies have looked at hearing in these children, and the findings are subtly concerning even though no individual child in either study met the clinical definition of hearing loss. As a group, children with JIA showed statistically significant elevations in hearing thresholds at several frequencies compared with healthy controls, particularly at higher frequencies.10PubMed. Hearing loss and middle ear involvement in patients with juvenile idiopathic arthritis A second study found sub-clinical sensorineural hearing changes that were detectable on high-frequency audiometry and otoacoustic emission testing but invisible on conventional hearing tests.11PubMed. Audiovestibular function in patients with juvenile idiopathic arthritis (JIA)
Disentangling the contribution of the disease itself from the contribution of the medications is the central difficulty here. JIA involves systemic inflammation, which could independently affect the inner ear. But the pattern of sub-clinical, high-frequency hearing changes is characteristic of drug-related ototoxicity rather than inflammatory damage, which is suggestive. For parents of children on long-term NSAID therapy, the evidence doesn’t call for alarm but does argue for periodic hearing checks, especially high-frequency audiometry that goes beyond the standard screening range.
Why Standard Hearing Tests Miss Early Damage
One reason NSAID-related hearing changes fly under the radar is that standard audiometry tests only frequencies between 250 and 8,000 Hz, roughly the range used for speech. Ototoxic damage from medications almost always shows up first at higher frequencies, well above the speech range, where you wouldn’t notice it in daily conversation. Research on ototoxicity monitoring found that when patients’ hearing declined during treatment with known ototoxic drugs, nearly two-thirds showed the initial loss exclusively in the high-frequency range above 8,000 Hz. Only about 14% showed early loss in the conventional range alone. Testing a tailored set of high frequencies specific to each individual’s hearing profile would have caught about 90% of ears showing change.12PubMed. High-frequency audiometric monitoring strategies for early detection of ototoxicity
That study focused on aminoglycoside antibiotics and cisplatin chemotherapy rather than NSAIDs, so the monitoring protocol doesn’t translate directly. But the principle is the same: if ototoxic damage starts at frequencies above the standard test range, you won’t catch it with a standard test. The sub-clinical changes seen in the JIA children mentioned above fit this pattern perfectly. Extended high-frequency audiometry isn’t part of routine medical care, but if you’re on long-term NSAID therapy and want to track whether your hearing is changing, asking for testing up to 16,000 or 20,000 Hz would give a much earlier warning than a standard screening.
Reversibility and When to Worry
For most people taking NSAIDs at standard over-the-counter doses for short periods, ototoxicity is not a practical concern. The hearing effects of aspirin, the best-studied NSAID in this regard, are reversible once the drug clears your system. Even at doses high enough to produce noticeable tinnitus, hearing typically returns to normal within 24 to 72 hours after stopping. The story is less clear for non-aspirin NSAIDs. The case reports of sudden sensorineural hearing loss from naproxen, for instance, suggest that in rare circumstances the damage may not fully reverse.
Duration of use is probably the most important variable. The population studies consistently show that risk increases with longer use, particularly beyond several years of regular consumption. If you take ibuprofen for a headache twice a month, the ototoxic risk is negligible. If you take it daily for chronic back pain for a decade, you’re in the exposure range where measurable hearing effects have been documented in large cohorts. The trouble is that people in the latter group are often managing real, significant pain, and the hearing risk needs to be weighed against the benefit of pain control rather than viewed in isolation.
Older Adults and Compounding Risk Factors
Age-related hearing loss is the most common sensory deficit in older adults, and it develops through many of the same cochlear mechanisms that NSAIDs affect: reduced blood flow, oxidative stress, and gradual loss of outer hair cells. When someone whose cochlea is already under strain from aging adds a drug that further reduces cochlear blood flow and interferes with hair cell function, the combined effect can be larger than either factor alone. The 45% increased risk of progressive hearing loss associated with long-term NSAID use mentioned earlier came from a dataset spanning 40 years, a timeframe that inevitably captures the interaction between drug exposure and aging.5Frontiers in Neuroscience. Age-related hearing loss in older adults: etiology and rehabilitation strategies – Section: 3.2.5 Ototoxic drugs
Older adults are also more likely to be taking multiple medications that affect hearing. Loop diuretics, certain antibiotics, and some chemotherapy agents are all established ototoxins, and combining them with regular NSAID use could compound the risk. If you’re over 65 and taking NSAIDs regularly alongside other medications, it’s worth having a conversation with your pharmacist or doctor about the cumulative ototoxic load rather than evaluating each drug in isolation.
How NSAIDs Compare with Other Common Ototoxins
In the hierarchy of ototoxic medications, NSAIDs sit in the lower-risk tier. Aminoglycoside antibiotics like gentamicin and platinum-based chemotherapy drugs like cisplatin are at the top, capable of causing severe, permanent hearing loss that can affect daily communication. Loop diuretics like furosemide occupy a middle ground, with reversible effects at typical doses but potential for serious damage at high intravenous doses. NSAIDs generally cause milder effects, and most of those effects resolve when the drug is stopped.
The exception, as noted earlier, is topical NSAID application to the ear with a damaged eardrum, where local concentrations can rival those of gentamicin in terms of ototoxic impact.8International Journal of Pediatric Otorhinolaryngology. Ototoxicity associated with topical administration of diclofenac sodium as an otic drop: An experimental animal study But for oral NSAIDs at standard doses, the risk profile is closer to a slow background contribution to hearing decline rather than the dramatic damage associated with the heavy-hitter ototoxins. The catch is prevalence: because hundreds of millions of people use NSAIDs regularly, even a small per-person risk translates into a large number of affected individuals at the population level.
Practical Steps If You’re Concerned
If you use NSAIDs occasionally for acute pain, the ototoxic risk is essentially a footnote. The evidence links hearing effects to regular, sustained use over months to years, not occasional use. If you’re a chronic user, a few sensible steps can help you stay ahead of any potential changes:
- Track your baseline: If you’re starting long-term NSAID therapy, getting a baseline audiogram that includes high frequencies (up to 16,000 Hz or higher) gives you a reference point for comparison later.
- Watch for tinnitus: Ringing or buzzing in the ears is often the first sign of NSAID-related ototoxicity. If it appears after increasing your dose or starting a new NSAID, mention it to your prescriber.
- Minimize combined exposures: If you’re already exposed to loud noise regularly or taking other potentially ototoxic medications, adding daily NSAIDs stacks the risk. Hearing protection in noisy settings becomes even more important.
- Use the lowest effective dose: Both the cochlear blood flow effects and the direct hair cell effects are dose-dependent. This is standard advice for NSAIDs for many reasons, and hearing preservation is one more.
The conversation around NSAIDs and hearing loss is still evolving. Most of the population-level evidence comes from observational studies that can identify associations but can’t definitively prove causation. Randomized trials specifically designed to measure NSAID ototoxicity in humans are lacking, partly because the effect is subtle and develops slowly. What exists is a consistent signal across multiple study designs and populations pointing in the same direction: regular, long-term NSAID use is associated with a modest but real increase in hearing loss risk, and the biological mechanisms to explain it are well established.